DT
HealthMore in Health→
The Next Shot: How GLP-1 Research Is Rewriting the Future of Weight Loss Medicine
Key Takeaways
- One in eight U.S. adults now takes GLP-1 medications like Ozempic or Wegovy for weight management
- GLP-1 drugs activate the brain's stress response system, elevating cortisol and causing muscle loss
- Patients who stop treatment experience rebound overeating driven by chronically stimulated stress hormones
- Combination therapy with anti-CRH antibodies preserved muscle and maintained weight loss after drug discontinuation
- Human clinical trials of the combination approach are being planned pending partnership development
DE
DT Editorial Team··6 min read·via medicalxpress.com